Clinical Trials · NCT01620528
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Enrollment
- 872
- Start date
- May 2012
- Locations
- See registry
- Primary endpoint
- Percentage of Responders at Month 3 Based on Daily Assessment of Dysmenorrhea (DYS)